Amgen stock price forecast has been revised upward to $304 after

Amgen stock price forecast has been revised upward to $304 after the company reported stronger-than-expected oncology drug revenues; volume surges indicate continued investor confidence in the pipeline. Wall Street posts modest gains as shutdown begins and jobs data disappoints, but optimism around earnings and rate cuts keeps markets afloat. Please try using other words for your search or explore other sections of the website for relevant information. Despite broader biotech pullbacks, Amgen’s strong fundamentals push its stock price forecast to $301, backed by high gross margins and steady cash reserves that support R&D expansion.